FDA evidence audit: KPV human exposure
FDA states it has not identified human exposure data on drug products containing KPV by any route.
What this study tells us
This is a regulator evidence review, not a participant treatment trial. It is useful for showing what human exposure or safety evidence the regulator could — or could not — identify.
No human drug-product exposure identified
Not applicable — this is a regulator evidence review, not a participant trial.
FDA states it has not identified human exposure data on drug products containing KPV by any route.
Cell and animal studies are not evidence of human drug exposure.
Need help with terms such as randomized, placebo, endpoint or sample size? Open the glossary →
Key result
FDA states it has not identified human exposure data on drug products containing KPV by any route.